438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer

• Michael Gibson,
• Ammar Sukari,
• Julie Bauman,
• Tanguy Seiwert,
• Barbara Burtness,
• Sara Pai,
• Cristina Rodriguez,
• Bonnie Glisson,
• Kenneth Pienta,
• Francis Worden,
• Lara Dunn,
• Douglas Adkins,
• Christine Chung,
• A Dimitrios Colevas,
• Lori Wirth,
• Nabil Saba,
• Laura Agensky,
• Matteo Levisetti,
• Reena Lynam,
• Steven Margossian,
• Raymond Moniz,
• Steve Quayle

Affiliations

Michael Gibson

Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Ammar Sukari

Aff238 grid.254444.70000000114567807Karmanos Cancer Institute Detroit MI USA

Julie Bauman

1University of Arizona, Tuscon, AZ, USA

Tanguy Seiwert

Aff247 grid.170205.10000000419367822University of Chicago, Chicago Chicago IL USA

Barbara Burtness

Aff8 grid.47100.320000000419368710Yale University School of Medicine New Haven CT USA

Sara Pai

6Massachusetts General Hospital, Boston, MA, USA

Cristina Rodriguez

4Henry Ford Hospital, Detroit, MI, USA

Bonnie Glisson

University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kenneth Pienta

2Johns Hopkins University School of Medic, Baltimore, MD, USA

Francis Worden

2University of Michigan, Ann Arbor, MI, USA

Lara Dunn

5Memorial Sloan Kettering Cancer Center, New York, NY, USA

Douglas Adkins

Washington University School of Medicine, St. Louis, MO, USA

Christine Chung

1H. Lee Moffitt Cancer Center, Tampa, FL, USA

A Dimitrios Colevas

2Stanford University School of Medicine, Stanford, CA, USA

Lori Wirth

6Massachusetts General Hospital, Boston, MA, USA

Nabil Saba

11Emory University, Atlanta, GA, USA

Laura Agensky

15Cue Biopharma Inc, Cambridge, MA, USA

Matteo Levisetti

15Cue Biopharma Inc, Cambridge, MA, USA

Reena Lynam

15Cue Biopharma Inc, Cambridge, MA, USA

Steven Margossian

15Cue Biopharma Inc, Cambridge, MA, USA

Raymond Moniz

15Cue Biopharma Inc, Cambridge, MA, USA

Steve Quayle

15Cue Biopharma Inc, Cambridge, MA, USA